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ABSTRACT OF THE THESIS 
 
Modeling spinal bulbar muscular atrophy in vitro using human skeletal muscle derived 
from induced pluripotent stem cells 
 
by 
Garrett Ryan Wong 
Master of Science in Biology 
University of California, San Diego, 2017 
Professor Albert La Spada, Chair 
Professor Nicholas Spitzer, Co-Chair 
 
Spinal bulbar muscular atrophy is a motor neuron disease caused by a poly-
glutamine (polyQ) expansion in the first exon of the androgen receptor (AR) on the X 
chromosome. The expanded AR demonstrates a pathogenic protein causing autophagy 
dysregulation in neurons and skeletal muscle through alterations AR nuclear 
translocation. Until a few years ago, it was widely believed that the atrophy of the 
skeletal muscle was due to the loss of motor neurons, but recent studies supported the 
 
 
x 
 
skeletal muscle’s contribution in the disease. One of these studies involved the muscle 
specific knockdown of the mutant AR, leading to a complete rescue of mouse. 
Additionally, SBMA patients’ skeletal muscle biopsies expressed signs of myopathy and 
changes in mitochondria morphology. With the field shifting towards examining skeletal 
muscle’s role in SBMA, there is a need for an in vitro human skeletal muscle model of 
SBMA. Using skeletal muscle derived from human induced pluripotent stem cells 
(hiPSCs) from patients, this study hoped to determine if SBMA skeletal muscle exhibits a 
relevant phenotype of SBMA disease in a dish.  hiPSCs were differentiated into skeletal 
muscles through over expression of the myogenic transcription factor (MyoD) and 
chromatin remodeling protein (BAF60C) followed by culturing the cells with horse 
serum. SBMA skeletal muscles with an expanded AR expressed an increase in toxicity 
characterized by increased mitochondria fragmentation and DNA damage via double 
stranded breaks. These results established a possible platform for in vitro SBMA disease 
modeling and drug screening. 
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INTRODUCTION 
1.1 Spinal Bulbar Muscular Atrophy 
SBMA is a trinucleotide repeat disorder characterized by an expanded poly-Q 
(poly-glutamine or CAG repeats) region in the first exon of the AR on the X chromosome 
(La Spada, 1991). This disease belongs to a group of 9 diseases with polyQ expansions in 
coding regions of the genome, which include dentatorubral-pallidoluysian atrophy, 
Huntington’s disease and specific types of spinocerebellar ataxia (type 1, 2, 3, 6, 7, 17), 
all of which are neurological diseases (Cortes & La Spada, 2015; MacDonald, 1993). 
SBMA is partially penetrant in patients with CAG repeats between 36 and 39 and fully 
penetrant with greater than 40 repeats (Fischbeck, 1997). AR is a transcription factor that 
upon biding it’s ligand testosterone, dimerizes and translocate to the nucleus (Cary & La 
Spada, 2008). AR plays an important role in sexual development (Quigley, 1995). It is 
also expressed in early tissues like the spinal cord where it has been hypothesized to play 
a role in maintenance and development of somatic tissues (Cary & La Spada, 2008; 
Marron, 2005). Terminally differentiated cells like skeletal muscles and neurons require 
androgens to reach maturity (Cary & La Spada, 2008). Neurons use testosterone to 
develop neurites, and muscles require androgens differentiate to skeletal muscles from 
mesenchymal cells (Marron, 2005; Sinha-Hikim, 2004). The activated AR complex also 
plays a role in Ca
2+
 signaling and Akt signaling to promote maintenance and survival of 
AR expressing tissues (Cary & La Spada, 2008). Wild-type AR has been shown to have a 
neuroprotective effect, and the decline of testosterone expression with age is linked to 
disease progression in androgen receptive tissues like the prostate and neurons 
(Jayaraman, 2014). The expanded poly-glutamine tract of the first exon results in a 
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pathogenic protein, causing dysregulation in the AR of cells that this protein is primarily 
expressed in, neurons and skeletal muscles (Cary & La Spada, 2008; La Spada, 1991). 
SBMA symptoms manifest after maturity in patients’ forties or fifties when 
androgen expression drops (Dejager, 2002; Labrie, 1997). Clinically, patients have 
muscle cramps, weakness in facial muscles, difficulty breathing and swallowing as well 
symptoms of androgen insensitivity like infertility and gynecomastia (Quigley, 1995). 
Since males express androgens at higher levels, SBMA mice are all male, and if female 
carrier mice are given androgens, they will also develop symptoms of muscular atrophy 
and neurodegeneration (Katsuno, 2002). SBMA causes degeneration in the lower motor 
neurons and bulbar neurons along with atrophy of skeletal muscles, which means 
coordinated movement is still intact(Quigley, 1995). Unlike other motor neuron diseases, 
such as ALS, only the lower motor neurons are affected in SBMA, which makes it an 
unique characteristic of the disease (Quigley, 1995). Muscular atrophy seen in SBMA 
was thought to be caused by the increased degeneration of the lower motor neurons 
causing a loss in synaptic activity in the muscles, but more recent studies think that 
skeletal muscle may contribute to some of the phenotypes of SBMA (Cortes, 2014b). 
1.2 Modeling SBMA using iPSCs 
The first successful generation of a clonal embryo was demonstrated in 1962, 
which showed that somatic cells could be successfully reprogrammed into an embryo 
genetically identical to the donor somatic cell (Gurdon, 1962; Gurdon, 1958). Around 
this time, lines of mouse embryonic stem cells were isolated from inner cell mass of the 
blastocyst, which had the ability to differentiate into each germ layer (Evans & Kaufman, 
1981; Martin, 1981). However, the use of human embryonic stem cells (hESCs) was 
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more controversial than mice due to the use of left over in vitro fertilization zygotes, 
nevertheless some stable lines were still used to generate different cell types (Thomson, 
1998). The ethical concerns made it more difficult to use hESCs, especially with labs 
demonstrating the ability to generate clones of mammals using somatic cell nuclear 
transfer into an enucleated egg (Wilmut, 1997). These early studies laid the foundation 
for the possibility of reprogramming human cells from somatic tissues.  Before the 
discovery of iPSCs, biologists were also investigating transdifferentiation, the 
differentiation of one mature cell type into another cell type without undergoing a stem 
cell stage. The first successful transdifferentiation was the conversion of fibroblasts to 
myoblasts via transfection of the myoblast determination protein (MyoD) (Davis, 1987). 
This was a significant development in how easily efficient transdifferentiation could be 
achieved upon transfection with the cDNA of a single transcription factor (Davis, 1987). 
Other cell types like macrophages and erythrocytes were able to directly differentiated 
from other tissues via transfection (Takahashi & Yamanaka, 2016).  Unfortunately, 
unlike pluripotent cells fibroblasts and other somatic cells will become senescent after a 
certain number of divisions and can not be passaged in a long term culture system 
(Hayflick, 1965; Hayflick & Moorhead, 1961). 
Both the ethical problems and the senescent cell problems were mostly solved by 
using human fibroblasts retrovirally tranduced with the Yamanaka factors (Oct3/4, Sox2, 
Klf4 and c-Myc) to generate induced pluripotent stem cells (iPSCs) (Takahashi, 2007; 
Takahashi & Yamanaka, 2006). The Yamanaka factors are the key transcription factors 
needed to return to  pluripotency, meaning that these cells can differentiate into any of the 
three germ layers (Takahashi, 2007). Using this method allows human iPSCs to be 
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generated without the need for somatic cell nuclear transfer that causes the ethical 
concerns of developing hESC lines from embryos (Takahashi, 2007). Another way to 
characterize iPSCs other than looking at differentiation potential is to look for other 
pluripotent markers, such as NANOG and Tra-1 to make sure cells are not just forced 
into the expression of the Yamanaka factors but can be maintained as iPSCs with a given 
media (Takahashi, 2007). 
1.3 Non-cell Autonomous Pathogenesis in Neurodegeneration  
Neurological diseases were originally thought to originate from a population of 
diseased neurons causing the characteristics of the disorder. Two separate studies in 
familial amyotrophic lateral sclerosis with mutations in the superoxide dismutase 1 
(SOD1) enzyme demonstrated while transgenic mice with neuron specific overexpression 
of mutant SOD1did not cause any changes in the onset loss of hindlimb strength when 
compared to the wild-type mice whereas ectopic expression of mutant SOD1 led to rapid 
degeneration of hindlimb grip strength (Lino, 2002; Pramatarova, 2001). Non-cell 
autonomy pathogenesis was further demonstrated in sporadic ALS when Re and 
company devised the first human cell co-culture system with astrocytes from patient 
cortex explants and motor neurons derived from hESCs (Re, 2014). These cells were co-
cultured and the neurons plated with sporadic ALS astrocytes experienced higher 
amounts of cell death than when plated with wild type astrocytes; further experiments 
found that media conditioned with sporadic ALS astrocytes was added to wild type motor 
neuron also caused increased motor neuron degeneration like the co-culture system (Re, 
2014). This suggests that there is some type of toxic factors secreted from the astrocytes 
that cause the degeneration of neurons (Re, 2014).  
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The non-cell autonomous degeneration studies in SBMA have looked at the 
increase in the creatine kinase levels in serum alongside the muscle weakness in patients 
(Sorarù, 2008). Normally, there is increase in creatine kinase levels among 
neurodegenerative diseases to help increase ATP availability in tissues with high energy 
consumption like neurons and muscles, but SBMA patients have much higher levels of 
creatine kinase with no observable correlation between creatine kinase serum levels and 
the progression of the disease (Sorarù, 2008). The disconnect between disease 
progression and blood creatine kinase concentration suggests that SBMA muscular 
atrophy does not just rely on the loss of the motor neuron stimulation of the muscle, 
suggesting a contribution from SBMA skeletal muscles and satellite cells to the overall 
progression of the disease (Sorarù, 2008). Their conclusions were supported by work 
from our lab studying transgenic mouse with ectopic expression of the mutant human AR 
expression crossed with mice carrying Cre recombinase expression controlled by a 
human skeletal actin promoter (Cortes, 2014a). The mice displayed motor neuron disease 
phenotypes such as decreased grip strength and decreased motor neuron area in the quadriceps, 
characteristic of SBMA mice (Cortes, 2014a). Using this bigenic mouse model, our group 
achieved a tissue specific knockout of the pathogenic protein through Cre recombinase 
expression in skeletal muscle (Cortes, 2014a). The bigenic mice were completely rescued 
from the SBMA phenotype in mice despite the mutant AR still being expressed in all 
other tissues including the neurons (Cortes, 2014a). Further studies conducted by our lab 
in collaboration with Ionis Pharmaceuticals used anti-sense oligonucleotides of the 
mutant AR that only affected peripheral tissues (Lieberman, 2014). The periphery-
specific knockdown demonstrated that the central nervous system does not seem to 
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contribute to the overall phenotype in the SBMA mice whereas the rescue after the 
knockdown in the skeletal muscle suggests that at least some of the disease is caused by 
the skeletal muscle (Lieberman, 2014). With the patient biopsies and the complete rescue 
of the transgenic mouse, this marks a departure from the cell autonomous 
neurodegeneration hypothesis thought to cause SBMA, and future research has had 
increased emphasis on the contribution of muscles on overall disease progression. 
1.4 Skeletal Muscle Differentiation from iPSCs 
There is a lack of protocols to successfully generate skeletal muscle via 
differentiation of iPSCs despite the existence of multiple efficient ways to generate 
neurons and astrocytes. With only a small number of ways to generate skeletal muscle 
with varying efficiency, it is difficult to study human skeletal muscles cell in vitro. One 
method involves a small molecule treatment of growth factors and inhibition of the bone 
morphogenetic protein signaling in iPSCs (Chal, 2016). This method does provide 
efficient myotube formation as other methods but does not have genome integration, 
,which avoids the issue of random construct integration disrupting other genes possibly 
causing unrelated phenotypes to arise (Chal, 2016). Another method without genome 
integration is the protocol developed by Genea BioCells using small molecules to 
generate myogenic precursors, which has shown to efficiently generate myotubes (Caron, 
2016). It has been long known that the key transcription factor for myoblast formation is 
MyoD (Davis, 1987). With the use of hESCs and iPSCs, scientists wanted to use the 
technology to generate myoblasts from these immortalized cell lines But stem cells did 
not easily enter the myogenic path without differentiation into an intermediate tissue 
using EBs or mesenchymal cells (Barberi, 2007; Darabi, 2012; Goudenege, 2012; 
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Iacovino, 2011). Along with MyoD, BAF60C was shown to be a necessary transcription 
factor to differentiate iPS into myoblasts through chromatin remodeling determining their 
fate as myoblasts (Albini, 2013). BAF60C is a protein in the SWItch/Sucrose Non-
Fermentable (SWI/SNF) chromatin complex necessary for chromatin remodeling to 
allow efficient binding of MyoD and subsequent transcription of myogenic factors 
(Albini, 2013; de la Serna, 2001). The SWI/SNF is an ATP-dependent complex that 
facilitates the movement of nucleosomes to facilitate the transcription of muscle specific 
genes like myogenin (Cairns, 2009; de la Serna, 2001). BAF60C is one of the 
components of the SWI/SNF complex that can be changed out for other protein 
combinations to remodel different parts of the genome (Chi, 2004; Wu, 2009). Through 
ectopic expression of MyoD, iPSCs were found to need BAF60C expression to undergo 
myogenic differentiation directly from pluripotent stem cells without the need for an 
intermediate mesoderm differentiation (Forcales, 2012). These factors can be used to 
reliably generate skeletal muscle from iPSCs when overexpressed in human iPSCs 
(Albini, 2013). 
With the ability to develop functional skeletal muscle, we study isolated skeletal 
muscles to understand the non-cell autonomous pathogenesis in SBMA. Skeletal muscles 
can be efficiently generated for high throughput analysis of mitochondria function, 
morphology, and overall cell health. 
 
1.5 Mitophagy 
Autophagy can be broken down into two types, non-selective and selective 
autophagy. While non-selective is a response to starvation, selective autophagy is used to 
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break down dysfunctional organelles and harmful protein aggregates like the ones that 
arise in disease like Huntington’s and SBMA (Ding & Yin, 2012; Nihei, 2013). One 
selective type of autophagy is the systematic breakdown of excess or non-functional 
mitochondria (Ding & Yin, 2012). Due to the high levels of reactive oxygen species, 
mitochondria are commonly broken down via a specific autophagy pathway called 
mitophagy (Scherz-Shouval, 2007). This process is regulated through mTOR or an 
autophagy related protein Atg4 where mitophagy is activated through the presence of 
reactive oxygen species or changes in the energy needs of the cell (Friedman & Nunnari, 
2014; Scherz-Shouval, 2007). 
As the location of oxidative phosphorylation, mitochondria are an essential part of 
eukaryotic metabolism. The mitochondria are used to form the substrates and 
compartmentalize the chemical gradient needed for the generation of ATP through the 
electron transport chain. The potential risk of reactive oxygen species is outweighed by 
the amount of energy that can be generated per substrate, which allows for high ATP-
consuming tissues like neurons and muscles. While the H
+
 ions are used for the 
phosphorylation of ADP into ATP, other ion gradients are used to maintain proper 
function of mitochondria like Ca
2+
 (Friedman & Nunnari, 2014).  In higher eukaryotes, 
the mitochondria are not usually expressed as single mitochondrion, but as a network of 
interconnected organelles (Friedman & Nunnari, 2014). This network helps maintain and 
evenly distribute the mitochondrial DNA (mtDNA) products to all mitochondria (Chen, 
2007). In order to maintain proper metabolic function and cellular energy needs, 
mitochondria undergo fusion and fission events to address the energy needs of the cell 
(Hoppins, 2007). Changes in the equilibrium between fusion and fission events can cause 
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mtDNA to become damaged, affecting overall mitochondria function (Hoppins, 2007). If 
fusion events become too infrequent, the mitochondria can become less interconnected 
and cause mitochondria fragmentation as they are separated from normally filamentous 
network (Chen, 2003). These more fragmented mitochondria are more likely to have 
damaged mtDNA and decreased mitochondria polarization needed for oxidative 
phosphorylation (Chen, 2005; Hoppins, 2007). Loss of the electrochemical gradient 
causes mitochondria to appear smaller and rounder than normal mitochondria (Gomes & 
Scorrano, 2008). When the electrochemical potential in mitochondria is disrupted, the 
depolarization can lead to mitophagy, which is normally used to breakdown and recycle 
the mitochondria (Lemasters, 1998; Matsuda, 2010). Mitophagy is regulated by both 
autophagy related genes (Atg) conserved across eukaryotes and another independent 
pathway that is thought to initiate mitophagy (Ding & Yin, 2012). In diseases like 
Parkinson’s disease and SBMA, changes in mitochondria form are characteristic of the 
disease and cause disruptions in normal cellular function (Matsuda, 2010; Ranganathan, 
2009). Some diseases with mitochondria dysfunction have lower mitochondria number 
and mass along with the depolarization due to changes in autophagic flux favoring the 
breakdown of mitochondria without being replenished (Ranganathan, 2009).  
Mitochondrial dysfunction in SBMA was first characterized using electron 
microscopy in MN-1 and PC12 cells from human and rat respectively (Ranganathan, 
2009). SBMA neurons expressed lower mitochondria mass and number alongside 
elevated mitochondria depolarization (Ranganathan, 2009). The changes in the 
mitochondria also reflected negative effects on overall cell health with increased 
apoptotic markers, such as reactive oxygen species and caspase 3 and 9 activity 
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(Ranganathan, 2009). Additionally, SBMA neuroprogenitor cells differentiated from 
iPSCs display the same mitochondria depolarization seen in the MN-1 and PC12 cells 
(Cortes, 2014b; Ranganathan, 2009). Neuroprogenitor cells were also shown to have 
increased number of LC3 positive puncta indicated more autophagosomes in the SBMA 
lines (Cortes, 2014b). These data supported a mitochondria phenotype and autophagy 
dysregulation in the neural cells. Muscle biopsies from SBMA patients have shown 
decreased number of mitochondria per fiber as well as changes in mitochondria 
morphology where the matrix density becomes too high or too low (Borgia, 2017). These 
abnormal mitochondria point toward a change in the mitochondria function 
(Ranganathan, 2009). While signs of mitophagy have been studied in patient samples, 
studies have not yet shown that skeletal muscles have a similar mitophagy in vitro.  
Changes in cell death and mitophagy can be quantified in a various ways where 
one can look at different characteristics representative of cellular stress. Mitophagy can 
be quantified via mitochondria depolarization or fragmentation (Friedman & Nunnari, 
2014). Loss of polarization of the mitochondria can be caused by cellular stress on 
transport proteins, which leads to mitochondrial fragmentation (Friedman & Nunnari, 
2014). Extended expression of mitochondria depolarization and spherical mitochondria 
are precursors of autophagy and apotosis within cells, which all can be examined via a 
JC-1 assay, electron microscopy, or fluorescence microscopy  (Lemasters, 1998; Menges, 
2017). The JC-1 assay uses a dye that localizes in the mitochondria with normal resting 
potential and fluoresce red, but upon depolarization the dye leaves the mitochondria and 
fluoresces green. Another way to look at autophagic, apoptoic or necrotic cells is 
examining samples for double stranded DNA breaks via a terminal deoxynucleotidyl 
11 
 
 
transferase dUTP nick-end labeling (TUNEL) assay, which uses fluorescent markers to 
identify the breaks as a sign of cytotoxicity in cells to identify apoptotic or autophagic 
cells (Elia, 1991; Negoescu, 1996). These methods are all efficient ways of examining 
cell health in vitro and ex vivo.  
This study tests if the differences in autophagic flux exhibited by iPSC-derived 
skeletal muscle of SBMA patients and evaluate if the derived skeletal muscle 
recapitulates some mitochondrial defect expressed in the SBMA mouse model and 
patient muscle biopsies. iPS-derived skeletal muscle will be analyzed via mitochondria 
depolarization, mitochondria fragmentation, and double stranded DNA breaks as 
measures of changes in autophagy. This study aims to understand possible disease related 
changes in SBMA skeletal muscles independent of motor neurons and if it can be used 
for in vitro drug screening to better understand the disease in human cells.
12 
 
MATERIALS AND METHODS 
2.1 Cell Lines 
iPSCs were previously reprogrammed as described in Cortes, 2014b. In short, 
fibroblasts from three SBMA patients and three controls were reprogrammed using 
retrovirus caring the four Yamanaka factors (Oct4, Sox2, Klf4, c-Myc). The iPSCs were 
maintained in mTeSR (StemCell Technologies) with daily media changes. Cells were 
mechanically passed every 5 days before colonies began to merge together or 
differentiate.  
2.2 MyoD and BAF60C constructs 
Constructs harboring doxycycline-inducible MyoD and BAF60C were kindly 
provided by Dr. Lorenzo Puri (Albini, 2013). The plasmids contain puromycin and 
blasticidin resistance genes on the MyoD and BAF60C constructs respectively. 
Constructs were tranfected into the iPSCs via nucleofection (Amaxa), and replated onto 
Matrigel in mTeSR supplemented with Rock inhibitor (5nM).     
2.3 Skeletal Muscle Differentiation 
iPSCs were treated with Rock inhibitor (5nM) in mTeSR 24 hrs before passing. 
Cells were enzymatically passed with Accutase, spun down, counted and 7.5x10
4
 cells 
were plated onto each well of 96-well plates and 1.0x10
6
 onto 6 well, in mTeSR 
supplemented with Rock inhibitor (5nM). The cells were left in mTeSR until the wells 
were 90% confluent (~48hrs), and the media was changes to human embryonic stem cell 
(HuES) media. HuES media is DMEM/F12 supplemented with glutamine, non-essential 
amino acids, 0.2% beta-mercaptoethanol, and 200ng/mL doxycycline. This media change 
is necessary to induce the overexpression of the MyoD and BAF60C constructs to 
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differentiate the iPSCs into myoblasts. After 48hrs, the media is changed to skeletal 
muscle media with DMEM/F12 supplemented with 2% horse serum, Glutamax, and 
1mM sodium pyruvate. The horse serum media allows the myoblasts to mature into 
skeletal muscles by allowing the myoblasts to fuse into skeletal muscles.  After 24hrs., 
dividing cells were selected against after with horse serum media supplemented with ara-
C (10μM) for 48hrs. and washed with PBS supplemented with 2.33mg/mL KCl to 
remove dead dividing cells while preventing spontaneous muscle contraction. Skeletal 
muscles had the media changed every 24hrs and kept in culture for up to 3 weeks.  
2.4 Skeletal Muscle Immunostaining  
Cells were fixed in 4% PFA and permeabilized with 0.25% Triton-X with 3 
washes with PBS in-between. These were blocked in 3%BSA for 4hrs at room 
temperature. Primaries were added in 3%BSA after 3 washes with PBS. For looking at 
myoblast and skeletal muscle differentiation, samples were stained with MyoD (Santa 
Cruz M-318 1:50, Alexa 488) and MHC (DSHB MF-20 1:150, Alexa 555). Primary 
antibodies were incubated overnight at 4°C. Cells were washed with PBS 3 times before 
putting on the secondaries for one hour. Cells were counterstained with DAPI and then 
mounted using a coverslide and Prolong Gold (Thermo). Then, images were taken using 
the Zeiss apotome microscope at 40x.   
2.5 Mitochondria Depolarization 
From a 6-well plate of skeletal muscle that has been in 2% horse serum for 48hrs, 
the cells were dissociated using accutase, and 1.0x10
6
 cells were resuspended in 1mL of 
DMEM media and stained with the JC-1 dye for 30min. Cells were spun down and 
washed with PBS three times. The cells then were resuspended in PBS with DAPI to 
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stain the nuclei.  These cells were analyzed for JC-1 red and JC-1 green intensity using 
the NucleoCounter NC-3000.  The system analyzes the ratio of green to red intensity to 
generate a scatter plot to analyze the different populations of cells. Total mitochondria 
depolarization was quantified by normalizing the depolarization to a control line (SBMA 
5).  
2.6 Mitochondria Imaging 
Two-week old skeletal muscles were stained for Tom20 (Santa Cruz Biosciences 
(FL-145): sc-11415 1:500, Alexa 555) and MHC (DSHB MF-20 1:150, Alexa 488) with 
DAPI as the counterstain. These images were taken at 63x on an Zeiss Apotome 
Microscope. Non-overlapping muscle fibers were analyzed via the morphometry plugin 
(Dickey & Strack, 2011). The settings were 13 minimum particle size and 50 rolling ball 
background subtraction. Fragmentation was quantified using the average aspect ratio of 
each mask where the aspect ratio is the greatest diameter divided by the orthogonal 
diameter.  
2.7 TUNEL Imaging 
Two week old muscles (in 96-wells) were fixed with 4% PFA and 0.25% Triton-
X in PBS with 3 washes with PBS in between. Then, the staining followed the Click-iT 
TUNEL Alexa Flour 488 (Thermo) protocol with one DNase treated positive control and 
stained with MHC (DSHB MF-20 1:150, Alexa 555). These muscles were counterstained 
with Hoechst and mounted with Prolong Gold (Thermo). Images were taken on a Zeiss 
Apotome Microscope at 40x magnification. The percentage of TUNEL positive nuclei to 
total nuclei within in MHC positive fibers was analyzed in the Zeiss Zen imaging 
program.
15 
 
RESULTS 
3.1 Skeletal Muscle Differentiation 
First, lines of SBMA and control iPSCs needed to be efficiently differentiated into 
skeletal muscle. iPSCs were differentiated following a modified protocol from the Puri 
lab to generate myotubes in a 2D culture system (Fig. 1A). Six lines of iPSCs (3 controls 
and 3 SBMA) were nucleofected with doxycycline-inducible MyoD and BAF60C 
constructs with puromycin and blasticidin resistance and replated to be maintained for 
future passages. Nucleofected iPSCs are treated with puromycin and blasticidin to select 
for cells that had both constructs. The MyoD and BAF60C were induced with 
doxycycline, and 48 hours after the iPSCs are treated with doxycycline the cells are able 
to differentiate into myoblasts with nearly all nuclei with robust MyoD expression (Fig. 
1B). Differentiation from iPSCs to skeletal muscles takes about 7 days in 2% horse serum 
to devleop multiple MHC positive fibers with multiple nuclei characteristic of skeletal 
muscle. These stem cell lines retain their ability to differentiate into muscle after multiple 
mechanical passages. Spontaneous contractions can be observed after around 3 days in 
2%HS. Spontaneous contraction often leads to the skeletal muscle detaching from the 
plates; therefore, long-term culture of the skeletal muscles was performed using media 
supplemented with KCl to prevent spontaneous. After 14 days in 2%HS medium, the 
myotubes consistently display maturation, represented by increased number of 
multinucleated fibers and usually have thicker fibers than 7 days in the differentiation.  
3.2 Mitochondria morphology in SBMA myotubes 
Once skeletal muscles were generated and the protocol was optimized, the 
skeletal muscles differentiated from 3 controls and 3 SBMA iPSC lines were assessed for 
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mitochondria dysfunction in as other studies have shown some signs of mitophagy in 
patient skeletal muscle biopsies. The first mitochondrial aspect looked at was 
mitochondria depolarization to see if there was a difference in the number of depolarized 
mitochondria between the control and the SBMA muscles. After 48hrs in skeletal muscle 
differentiation media, the early iPSC-derived myotubes were assayed for mitochondrial 
depolarization, a precursor of mitophagy and apoptosis, through a JC-1 assay using image 
cytometry (Supplemental Fig. 1). Myoblasts were enzymatically dissociated and loaded 
into slides to be analyzed. These cells are graphed by JC-1 red to JC-1 green ratio. High 
JC-1 green and low JC-1 red intensity were indicative of mitochondria depolarization, 
which separated the cell populations into two groups as indicated by the quandrants with 
polarized mitochondria above the curve and depolarized mitochondria below it. The 
populations were normalized to the control lines to ensure that the gating did not change 
between different samples (n=8 for both control and SBMA). Using this assay we did not 
observe any statistical differences in mitochondrial depolarization, and there was high 
variability between each sample on different experimental replicates. 
Due to high variability in the JC-1 assay, we decided to investigate mitchondria 
function by characterizing the mitochondria morphology. Two-week old skeletal muscles 
were stained for Tom20, a protein located on the outer membrane of the mitochondria 
used as a mitochondrial marker (Fig. 2A). The mitochondria shape was investigated for 
any irregularities in the mitochondria network in SBMA myotubes. Only MHC-positive 
fibers were examined to ensure the fibers analyzed were muscles, and non-overlapping 
fibers were examined to make sure the overlapping mitochondria do not interfere with the 
automated measurement of the mitochondria tubularity.  When examining the 
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mitochondria, the measurement quantified was aspect ratio, the greater axis divided by 
the lesser axis of mitochondria. The aspect ratios closer to 1 represent more circular 
mitochondria, and these suggest mitochondria fragmentation. In our analysis, SBMA 
mitochondria display mitochondria with 10% smaller aspect ratio compared to the 
mitochondria from control derived skeletal muscles, indicating rounder, therefore more 
fragmented mitochondria in the SBMA skeletal muscle. (Fig.2B) 
 
3.3 TUNEL in SBMA myotubes 
With a difference observed in the mitochondria aspect ratio, the overall cell health 
was looked at using a TUNEL assay. This assay looks at the amount of cells dying was 
quantified by determining if there are double stranded breaks in the DNA. The reaction 
adds dUTP to the blunt end double stranded breaks found in the nucleus, which can be 
marked with a fluorescent protein to cause autophagic nuclei to fluoresce and be 
quantified via microscopy (Fig. 3A). The percentage of TUNEL positive nuclei was 
quantified by counting the number of TUNEL positive nuclei in the MHC-positive nuclei 
(Fig. 3B). Two-week old muscle was used to determine the percentage of autophagic 
cells. The SBMA lines of skeletal muscle had about 25% more TUNEL positive cells 
than the control lines. From the TUNEL results, there is an indication of more apoptotic 
and autophagic cells in the SBMA skeletal muscle lines.
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DISCUSSION 
Skeletal muscle was successfully generated using our optimized protocol and treatment 
with horse serum. The efficiency varied between samples but treatment with ara-C reduced the 
number of dividing contaminant cells, therefore increasing homogeneity of the culture. Re-plating 
the cells work both as iPSCs with rock inhibitor and as myoblasts where the iPSC dissociation 
usually has more contaminant cells, but treatment with Ara-C resolves that issue. Some non-
MHC positive cells remained, which may have been senescent cells left behind after the 
enzymatic passage. nThe differentiation protocol was an efficient method for generating 
myotubes to be analyzed for different types of assays in high throughput scenarios. The use of 
horse serum is a good candidate for looking at the possible phenotypes of SBMA skeletal muscle 
due to the high levels of androgens present in the serum. This helped with both the skeletal 
muscle maturation and subsequent analysis of the skeletal muscle in the scope of SBMA disease 
modeling. Nucleofected iPSCs can be maintained for multiple passages and frozen down while 
retaining their ability to differentiate into skeletal muscle. Compared to other methods this does 
use genome integration to generate skeletal muscles, but the high differentiation efficiency and 
relatively short differentiation timeline of 10 days makes this consistent way to generate skeletal 
muscles. These will be used for future studies into the interaction between SBMA neurons and 
muscle to study the disease at the NMJ in vitro.  
With no differences in mitochondrial depolarization, the data do not show any difference 
in mitophagy (n=8 for JC-1 assay for control and affected). Due to SBMA being a late onset 
neurodegenerative disease, it is possible that naïve myotubes with little myosin heavy chain 
expression for 48hrs in 2% HS will not express the stereotypical mitochondria stress seen in 
patient muscle (Borgia et al., 2017).  Furthermore, the JC-1 assay is not efficient when using 
mature myotubes because the muscle fibers have multiple nuclei, which makes it more difficult 
for an assay that requires cells to dissociated into single cells.  To look at mitochondria 
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dysfunction, there is a need for an assay that does not use image cytometry and single cell 
dissociation.  
Along with the difficulty of using mitochondria depolarization to look at mitophagy, this 
lack of phenotype in early myotubes encouraged looking at mitochondria fragmentation through 
immunostaining to see if there is a diseased phenotype in mature SBMA muscles. This allowed 
muscles to express more MHC positive cells and fuse while still being able to analyze mitophagy 
through image analysis. The derived SBMA skeletal muscles displayed a lower aspect ratio than 
that of the control myotubes, which means the mitochondria are more circular. Rounder 
mitochondria are a possible indicator of mitochondria fragmentation and possibly mitophagy 
(Gomes & Scorrano, 2008). Healthy mitochondria have aspect ratios from 2.0 to 3.0, but more 
fragmented mitochondria usually have aspect ratios lower than 1.6 (Dickey & Strack, 2011). We 
analyzed the average aspect ratio of a cell or fiber, which is more reflective of the overall 
fragmentation. In more fragmented cells, mitochondria would have less filamentous mitochondria 
indicative of increased macroautophagy when compared to their more tubular counterparts 
(Friedman & Nunnari, 2014). The lower aspect ratio was an exciting result because the signs of 
mitophagy in skeletal muscle meant that there is the possibility of functional differences in the 
mitochondria of SBMA and control skeletal muscle. These results align with the other findings of 
mitochondria dysfunction that has been described in the patient biopsies (Borgia et al., 2017). In 
order to determine if the mitochondria are dysfunctional, a functional assay of the mitochondria is 
needed to quantify the differences between the SBMA and control myotubes. Quantifying the 
number of mitochondria in a given fiber and looking at mitochondria localization to 
autophagosomes or lysosomes would be efficient ways to confirm the change in mitophagy or 
mitochondrial function suggested by the smaller aspect ratio.  
The higher percentage of TUNEL-positive cell reflects that there is an increase in the 
number of autophagic cells compared to the control myotubes. The TUNEL percentage of the 
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control myotubes is relatively high, which may have been caused by longer culture period of two 
weeks. Looking at TUNEL helps determine if there are differences in overall cell health between 
the SBMA and control cells. One possibility is that mitochondrial dysfunction is causing changes 
to overall cell viability. Loss of overall mitochondria number or decrease in function 
mitochondria are both ways that may cause stress on the cells because they are not able to sustain 
the high levels of ATP production needed in skeletal muscles    
With these results, the iPSC generated skeletal muscles establish an efficient way to 
generate model SBMA relevant phenotype that can be used in drug screening. These results 
represent neuron independent in vitro phenotypes of SBMA, which support previous findings 
suggesting non-cell autonomous neurodegeneration in SBMA.  
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Figure 1: Skeletal muscle differentiation from iPSCs. A. Schematic representation of the differentiation 
protocol. B. Immunohistochemistry of the myoblasts and myotubes. The myoblasts show MyoD 
expression. Myotubes are multinucleated with consistent MHC expression. Scale bars represent 100μm.
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Figure 2: Lower mitochondria aspect ratio in SBMA myotubes. A.) Two-week old differentiated skeletal 
muscles expressing Tom20 and MHC. B.) The average mitochondria aspect ratio of each MHC positive 
muscle fibers analyzed (Analyzed fibers with n=118 control, n=161 SBMA, p<0.0001). 
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Figure 3: Increased TUNEL positive nuclei in SBMA myotubes. A.) TUNEL analysis of skeletal muscles 
from control and SBMA iPSCs. Arrows represent TUNEL-positive (green) nuclei in MHC (red) positive 
fibers. B.) The quantification of the number of TUNEL positive cells (N=4 and N=6, groups analyzed with 
6 microscope images).  Scale bars represent 100μm.  
24 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure S1: Early myotubes have variable levels of mitochondria depolarization. Mitochondria 
depolarization determined through JC-1 assay and flow cytometry. The cell population in the bottom right 
quadrant represents the cells with depolarized mitochondria. Samples were analyzed after 48hrs in 
differentiation media (2% HS). Increased red:green ratio indicates healthy cells with polarized 
mitochondria whereas lower red:green ratio indicate depolarized mitochondria. The quadrants were drawn 
on a control sample and applied to the SBMA samples.
b) 
Control SBMA 
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